Table 1 Characteristics of PLWHA in Taiwan (2000–2014).

From: Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS

Characteristics

PLWHA receiving HAART (n = 19280)

PLWHA not receiving HAART (n = 6978)

P value

Age, yr

Mean ± SD

32.45 (10.31)

31.88 (9.73)

<0.001

15–49

17955 (93.13)

6599 (94.57)

<0.001

≥50

1325 (6.87)

379 (5.43)

 

Sex

Female

1124 (5.83)

490 (7.02)

<0.001

Male

18156 (94.17)

6488 (92.98)

 

Injecting drug uses

No

15749 (81.69)

3773 (54.07)

<0.001

Yes

3531 (18.31)

3205 (45.93)

 

Income level

Low

10473 (54.32)

4693 (67.25)

<0.001

Intermediate

6231 (32.32)

1842 (26.40)

 

High

2576 (13.36)

443 (6.35)

 

Urbanization

Rural

6009 (31.17)

2695 (38.62)

<0.001

Urban

13271 (68.83)

4283 (61.38)

 

AIDS status

No

9034 (46.86)

6179 (88.55)

<0.001

Yes

10246 (53.14)

799 (11.45)

 

Comorbidity

Diabetes

1040 (5.39)

292 (4.18)

<0.001

Chronic kidney disease

823 (4.27)

224 (3.21)

<0.001

Congestive heart failure

259 (1.34)

77 (1.10)

0.127

Hypertension

2613 (13.55)

568 (8.14)

<0.001

COPD

1140 (5.91)

206 (2.95)

<0.001

Cancer

3153 (16.35)

753 (10.79)

<0.001

Cerebral vascular disease

503 (2.61)

158 (2.26)

0.115

Follow-up years

Mean ± SD

6.03 (3.86)

4.86 (3.55)

<0.001

  1. *Unless stated otherwise. PLWHA = people living with HIV/AIDS; SD = standard deviation; HAART = highly active anti-retroviral therapy; AIDS = acquired immunodeficiency syndrome; COPD = chronic obstructive pulmonary disease.